Asia Pacific Antibiotics Markets, 2020-2021 & Forecast to 2026 by Action Mechanism, Drug Class, Country, Industry Analysis and Forecasts – ResearchAndMarkets.com

Asia Pacific Antibiotics Markets, 2020-2021 & Forecast to 2026 by Action Mechanism, Drug Class, Country, Industry Analysis and Forecasts – ResearchAndMarkets.com




Asia Pacific Antibiotics Markets, 2020-2021 & Forecast to 2026 by Action Mechanism, Drug Class, Country, Industry Analysis and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Antibiotics Market By Action Mechanism, By Drug Class, By Country, Industry Analysis and Forecast, 2020 – 2026” report has been added to ResearchAndMarkets.com’s offering.

The Asia Pacific Antibiotics Market is expected to witness market growth of 6.6% CAGR during the forecast period (2020-2026).

The antibacterial agent is another name of antibiotics that has the capability to kill or slow down bacterial growth. It is widely used for curing and preventing diseases caused by bacteria. The increasing number of patients who are suffering from infectious diseases and the evolution of the latest diagnostic devices are some of the major factors that drive the market.

The antibiotics market is growing owing to the increasing consumption of antibiotics in middle and lower-income countries, huge investments in R&D activities by pharmaceutical companies, and the increasing number of infectious diseases. Although, the development of antibiotic resistance and the rising cost of drug approval hinder the growth of the antibiotic market.

On the other hand, advanced prospect molecules and the development of novel combination therapies to cure antibiotic-resistant microbial infections are estimated to propel the market and provide great opportunities for the market players.

With the increasing incidents of infectious diseases, many companies in the market are actively taking efforts for the innovation of advanced products that will propel the growth of the market. There are many infections that become resistant to antibiotics; this situation provides an opportunity for companies to develop advanced products.

These advanced products increase the range of treatment by the antibiotics that further support the growth of the market. The innovation of advanced prospect molecules and development of some novel combination therapies which cure antibiotic-resistant infections are expected to support the market growth.

Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company

Key Topics Covered:

Chapter 1. Market Scope & Methodology

1.1 Market Definition

1.2 Objectives

1.3 Market Scope

1.4 Segmentation

1.4.1 Asia Pacific Antibiotics Market, by Action Mechanism

1.4.2 Asia Pacific Antibiotics Market, by Drug Class

1.4.3 Asia Pacific Antibiotics Market, by Country

1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction

2.1.1 Overview

2.1.2 Market composition and Scenario

2.2 Key Factors Impacting the Market

2.2.1 Market Drivers

2.2.2 Market Restraints

Chapter 3. Competition Analysis – Global

3.1 Cardinal Matrix

3.2 Recent Industry Wide Strategic Developments

3.2.1 Partnerships, Collaborations and Agreements

3.2.2 Product Launches and Product Expansions

3.2.3 Approvals

3.2.4 Acquisition and Mergers

3.3 Top Winning Strategies

3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)

3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Jul) Leading Players

Chapter 4. Asia Pacific Antibiotics Market by Action Mechanism

4.1 Asia Pacific Cell Wall Synthesis Inhibitors Market by Country

4.2 Asia Pacific Protein Synthesis Inhibitors Market by Country

4.3 Asia Pacific DNA Synthesis Inhibitors Market by Country

4.4 Asia Pacific RNA Synthesis Inhibitors Market by Country

4.5 Asia Pacific Mycolic Acid Inhibitors Market by Country

Chapter 5. Asia Pacific Antibiotics Market by Drug Class

5.1 Asia Pacific Cephalosporin Market by Country

5.2 Asia Pacific Penicillin Market by Country

5.3 Asia Pacific Fluoroquinolone Market by Country

5.4 Asia Pacific Macrolides Market by Country

5.5 Asia Pacific Carbapenem Market by Country

5.6 Asia Pacific Aminoglycosides Market by Country

5.7 Asia Pacific Sulfonamides Market by Country

5.8 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Antibiotics Market by Country

6.1 China Antibiotics Market

6.1.1 China Antibiotics Market by Action Mechanism

6.1.2 China Antibiotics Market by Drug Class

6.2 Japan Antibiotics Market

6.2.1 Japan Antibiotics Market by Action Mechanism

6.2.2 Japan Antibiotics Market by Drug Class

6.3 India Antibiotics Market

6.3.1 India Antibiotics Market by Action Mechanism

6.3.2 India Antibiotics Market by Drug Class

6.4 South Korea Antibiotics Market

6.4.1 South Korea Antibiotics Market by Action Mechanism

6.4.2 South Korea Antibiotics Market by Drug Class

6.5 Singapore Antibiotics Market

6.5.1 Singapore Antibiotics Market by Action Mechanism

6.5.2 Singapore Antibiotics Market by Drug Class

6.6 Malaysia Antibiotics Market

6.6.1 Malaysia Antibiotics Market by Action Mechanism

6.6.2 Malaysia Antibiotics Market by Drug Class

6.7 Rest of Asia Pacific Antibiotics Market

6.7.1 Rest of Asia Pacific Antibiotics Market by Action Mechanism

6.7.2 Rest of Asia Pacific Antibiotics Market by Drug Class

Chapter 7. Company Profiles

  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company

For more information about this report visit https://www.researchandmarkets.com/r/eue65c

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900